TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23168021

Group type: EXPERIMENTAL
Intervention: GPi DBS
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: STN DBS
Number of subjects: 128
Study: 21742071

Group type: EXPERIMENTAL
Intervention: ronacaleret 200 mg twice daily
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: ronacaleret 400 mg once daily
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 19445553

Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oxycodone 5 mg and paracetamol 325 mg up to 8 hourly for >/= 6 weeks (group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oxycodone/paracetamol therapy (group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Oxycodone/paracetamol therapy (both groups)
Number of subjects: 150
Study: 16778460

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide (BP)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Salicylic acid (SA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Retinoic acid (RA)
Number of subjects: 6

Group type: COMPARATOR
Intervention: None of the agents
Number of subjects: 6
Study: 15308882

Group type: EXPERIMENTAL
Intervention: Losartan/Hydrochlorothiazide (LOS/HCTZ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ramipril (ACE inhibitor)
Number of subjects: 0
Study: 11787984

Group type: EXPERIMENTAL
Intervention: 100 mg iron daily
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: 15 mg iron daily (enriched with Zn, Cu, Se, vitamin B12, and folate)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (15 mg iron)
Number of subjects: 67
Study: 10193215

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Diamorphine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 160
Study: 8311225

Group type: EXPERIMENTAL
Intervention: 2% propofol emulsion
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1% propofol emulsion
Number of subjects: 0
Study: 3291161

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 130

Group type: COMPARATOR
Intervention: RT following chemotherapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: RT following low dose concurrent irradiation with chemotherapy (LDC‐RT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: RT concurrently used with chemotherapy
Number of subjects: 130
Study: 30791747

Group type: EXPERIMENTAL
Intervention: Targeted acupuncture (TA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nontargeted acupuncture (NTA)
Number of subjects: 30
Study: 27765707

Group type: EXPERIMENTAL
Intervention: Early physical therapy (initiated within 28 days of the index visit)
Number of subjects: 4723

Group type: COMPARATOR
Intervention: No early physical therapy
Number of subjects: 4723
Study: 25487817

Group type: EXPERIMENTAL
Intervention: DAPT with cilostazol and aspirin or clopidogrel
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Aspirin or clopidogrel monotherapy
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: DAPT with cilostazol and aspirin
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 4000
Study: 24157403

Group type: EXPERIMENTAL
Intervention: Exercise and calcium intake (Ex(+)Ca(+))
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise no-calcium intake (Ex(+)Ca(−))
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Calcium intake-no-exercise (Ex(−)Ca(+))
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-exercise-no-calcium intake (Ex(−)Ca(−))
Number of subjects: 48
Study: 22073891

Group type: EXPERIMENTAL
Intervention: Warm acupuncture combined with intra-articular injection of sodium hyaluronate
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (intra-articular injection of sodium hyaluronate only)
Number of subjects: 179
Study: 19373470

Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (0.1 mmol/kg body weight)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gd-DTPA (0.2 mmol/kg body weight)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Gd-BOPTA
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gd-DTPA
Number of subjects: 52
Study: 16810138

Group type: EXPERIMENTAL
Intervention: 10-contact, 20-week experimental intervention
Number of subjects: 222

Group type: COMPARATOR
Intervention: Conventional care control group
Number of subjects: 222
Study: 15285333

Group type: EXPERIMENTAL
Intervention: Solid dispersion of glibenclamide in Gelucire 44/14 (Formula 1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Solid dispersion of glibenclamide in polyethylene glycol 6000 (PEG 6000) (Formula 2)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Daonil tablets (Hoechst)
Number of subjects: 6
Study: 12738722

Group type: EXPERIMENTAL
Intervention: Erythropoietin (r‐HuEpo) 40,000 IU s.c. once weekly
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: T‐FHX regimen (paclitaxel, fluorouracil, hydroxyurea, radiation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no erythropoietin)
Number of subjects: 90
Study: 10957752

Group type: EXPERIMENTAL
Intervention: Estrogen alone or in combination with progestogens
Number of subjects: 775

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 775
Study: 9003922

Group type: EXPERIMENTAL
Intervention: Xenetix
Number of subjects: 120

Group type: COMPARATOR
Intervention: Omnipaque
Number of subjects: 120

Group type: COMPARATOR
Intervention: Iopamiro
Number of subjects: 120
Study: 1308305

Group type: EXPERIMENTAL
Intervention: Midazolam (0.10 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam (0.15 mg/kg)
Number of subjects: 60
Study: 3914075

Group type: EXPERIMENTAL
Intervention: PAM (pyridine aldoxime methiodide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PAC (pralidoxime, pyridine aldoxime methylchloride)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TMB4 (trimedoxime)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DMO4 (obidoxime, Toxogonin, LüH6)
Number of subjects: 0
Study: 3497885

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole suspension alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Co-trimoxazole suspension with pectin-kaolin
Number of subjects: 8
Study: 30377210

Group type: EXPERIMENTAL
Intervention: Rose geranium nasal spray
Number of subjects: 40
Study: 30851501

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Oblique subcostal transversus abdominis block (OSTAP)
Number of subjects: 68
Study: 27491758

Group type: EXPERIMENTAL
Intervention: Supplemental program for Head Start centers
Number of subjects: 0
Study: 25998421

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (70ml/day, 6.43mmol nitrate/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (placebo, 70ml/day, 0.07mmol nitrate/day)
Number of subjects: 48
Study: 23211565

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 21723064

Group type: EXPERIMENTAL
Intervention: Open-cell stents (Acculink)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Closed-cell stents (Xact)
Number of subjects: 40
Study: 19250841

Group type: EXPERIMENTAL
Intervention: Postoperative chemoembolization (group A, n = 86)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Preoperative chemoembolization (group B, n = 37)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Combined preoperative and postoperative chemoembolization (group C, n = 40)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Nonchemoembolization group (control, n = 118)
Number of subjects: 281
Study: 16734393

Group type: EXPERIMENTAL
Intervention: Home-based weight-bearing exercise for 30 months
Number of subjects: 160

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 160
Study: 14715856

Group type: EXPERIMENTAL
Intervention: Congenital adrenal hyperplasia (n = 13)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Familial male‐limited precocious puberty (n = 22)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Idiopathic short stature (n = 18)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Skeletal advancement
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Skeletal delay
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Skeletal maturation and hypothalamic‐pituitary‐gonadal axis maturation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Hypothalamic‐pituitary‐gonadal axis maturation
Number of subjects: 53
Study: 11715158

Group type: EXPERIMENTAL
Intervention: Structured personal care (intervention group)
Number of subjects: 874

Group type: COMPARATOR
Intervention: Routine care (comparison group)
Number of subjects: 874

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 874
Study: 9138166

Group type: EXPERIMENTAL
Intervention: High‐energy density amylase digested and then fermented porridge (FAD)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: High‐energy density amylase digested porridge (AMD)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Conventional low‐energy density porridge
Number of subjects: 87

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 87
Study: 8202969

Group type: EXPERIMENTAL
Intervention: Angiographic detection of ulcerated plaques
Number of subjects: 500
Study: 2853056

Group type: EXPERIMENTAL
Intervention: enoxacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: pipemidic acid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: norfloxacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ofloxacin
Number of subjects: 12
Study: 31736225

Group type: EXPERIMENTAL
Intervention: Nurse-led electronic communication intervention (Speak for Myself Voice)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31356468

Group type: EXPERIMENTAL
Intervention: PrEP intervention
Number of subjects: 255
Study: 29208831

Group type: EXPERIMENTAL
Intervention: Trypan blue dye (0.06%) irrigation in the capsular bag, 0.2 ml injected after cortical cleanup under air.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Balanced salt solution, 0.2 ml injected in a similar manner as the dye group.
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Trypan blue dye (0.06%) irrigation in the capsular bag.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Balanced salt solution.
Number of subjects: 50
Study: 26215904

Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 319

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 319
Study: 22823900

Group type: EXPERIMENTAL
Intervention: Self-directed bronchoscopy training using a portable, simple simulator
Number of subjects: 20

Group type: COMPARATOR
Intervention: No manual training (Control)
Number of subjects: 20
Study: 22018129

Group type: EXPERIMENTAL
Intervention: Gynol II vaginal gel
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl cellulose gel (HEC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No gel exposure
Number of subjects: 18
Study: 18298441

Group type: EXPERIMENTAL
Intervention: GLP-1 0.7 pmol kg(‐1) min(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GLP-1 1.2 pmol kg(‐1) min(‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: GLP-1 2.5 pmol kg(‐1) min(‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 17215610

Group type: EXPERIMENTAL
Intervention: Bereavement intervention program (10 sessions including Dan-jeon breathing, self-help group activities, and health examination)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Health examination (control group)
Number of subjects: 27
Study: 12588271

Group type: EXPERIMENTAL
Intervention: Digoxin (SDC 0.5-0.8 ng/mL, n = 572)
Number of subjects: 3782

Group type: EXPERIMENTAL
Intervention: Digoxin (SDC 0.9-1.1 ng/mL, n = 322)
Number of subjects: 3782

Group type: EXPERIMENTAL
Intervention: Digoxin (SDC >=1.2 ng/mL, n = 277)
Number of subjects: 3782

Group type: COMPARATOR
Intervention: Placebo (n = 2611)
Number of subjects: 3782
Study: 11369167

Group type: EXPERIMENTAL
Intervention: Intraportal nutrition (PN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Systemic nutrition (SN)
Number of subjects: 20
Study: 9398695

Group type: EXPERIMENTAL
Intervention: Oral 17 beta‐estradiol (2 mg/day)
Number of subjects: 8
Study: 7732287

Group type: EXPERIMENTAL
Intervention: Sexual promiscuity
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Exposure to Rx
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Genital infections
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Mycosis
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Infertility
Number of subjects: 4262

Group type: COMPARATOR
Intervention: Benign deteriorations or normality
Number of subjects: 4262
Study: 3524647

Group type: EXPERIMENTAL
Intervention: Augmentin
Number of subjects: 748

Group type: COMPARATOR
Intervention: oxytetracycline
Number of subjects: 748
Study: 31073087

Group type: EXPERIMENTAL
Intervention: Domiciliary oxygen therapy (DOXT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (ambient air)
Number of subjects: 30
Study: 28196287

Group type: EXPERIMENTAL
Intervention: Non-metal clasp dentures (NMCDs)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional metal clasp-retained dentures (MCDs)
Number of subjects: 28
Study: 23934354

Group type: EXPERIMENTAL
Intervention: Onlay mesh placement
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sublay mesh placement
Number of subjects: 80
Study: 23515219

Group type: EXPERIMENTAL
Intervention: High-salt diet (>200 mEq/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low-salt diet (<10 mEq/day)
Number of subjects: 13
Study: 20881884

Group type: COMPARATOR
Intervention: CR only (n=8)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CR + moderate-intensity exercise (n=15)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: CR + vigorous-intensity exercise (n=9)
Number of subjects: 32
Study: 19809299

Group type: EXPERIMENTAL
Intervention: Side-to-side choledochocholedochostomy with T-tube (n = 99)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Side-to-side choledochocholedochostomy without T-tube (n = 95)
Number of subjects: 194
Study: 16729780

Group type: EXPERIMENTAL
Intervention: Roflumilast 100 microg
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Roflumilast 250 microg
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 microg
Number of subjects: 693

Group type: EXPERIMENTAL
Intervention: Roflumilast (all doses)
Number of subjects: 693
Study: 15585624

Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) based immunotherapy
Number of subjects: 86
Study: 11322841

Group type: EXPERIMENTAL
Intervention: Immediate treatment (individualized stress management)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait list control (subsequently treated)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined sample (after treatment for wait list control)
Number of subjects: 60
Study: 9032045

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (80 parts per million)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control gas (nitrogen)
Number of subjects: 58
Study: 8302530

Group type: EXPERIMENTAL
Intervention: 40 mg/day of lovastatin
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 3558996

Group type: EXPERIMENTAL
Intervention: Azatadine (topical tricyclic antihistamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cold, dry air (CDA) challenge
Number of subjects: 0
Study: 29631804

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 608

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Higher baseline aortic-root SI (>9.1) and elastic modulus (EM >618 mm Hg)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Upper-quartile aortic-root EM (>914 mm Hg)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Higher EM groups
Number of subjects: 608
Study: 27602906

Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA) 120 mg/kg over 1 hour
Number of subjects: 3
Study: 25395386

Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational intervention with electronic reminders tailored to weather conditions, sent every 2 weeks by text message or email.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational intervention.
Number of subjects: 101
Study: 22310513

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training for 4 weeks, 30 seconds at 35 Hz for the first 2 weeks, 40 seconds at 40 Hz for the final 2 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group performing the same exercises without vibration stimulation
Number of subjects: 17
Study: 21495269

Group type: EXPERIMENTAL
Intervention: Calcigard‐10 softgel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalat 10 capsule
Number of subjects: 0
Study: 18594093

Group type: EXPERIMENTAL
Intervention: Polished cemented femoral component (Ra, 0.18 to 0.3 microm)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Precoated roughened cemented femoral component (Ra, 1.8 to 2.3 microm)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Both groups (Polished and Precoated roughened)
Number of subjects: 201
Study: 16109780

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 2726

Group type: COMPARATOR
Intervention: Enoxaparin (LMWH)
Number of subjects: 2726
Study: 12486418

Group type: EXPERIMENTAL
Intervention: Enalapril treatment
Number of subjects: 6797

Group type: EXPERIMENTAL
Intervention: Ejection fraction
Number of subjects: 6797

Group type: EXPERIMENTAL
Intervention: Ejection fraction scaled into tertiles
Number of subjects: 6797

Group type: EXPERIMENTAL
Intervention: Multifactorial baseline risk
Number of subjects: 6797
Study: 10399791

Group type: EXPERIMENTAL
Intervention: Elevated Gal(0)corr in SPA patients
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Elevated Gal(0)corr at 6-month follow-up
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Gal(0)corr levels
Number of subjects: 47
Study: 7673104

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 1639046

Group type: EXPERIMENTAL
Intervention: Individual dietary counselling aimed at reducing dietary fat intake to 20‐25% energy (E%)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No dietary advice
Number of subjects: 240
Study: 6492017

Group type: EXPERIMENTAL
Intervention: High stress/common fate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High stress/dissimilar fate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low stress/common fate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low stress/dissimilar fate
Number of subjects: 60
Study: 30910304

Group type: EXPERIMENTAL
Intervention: Chlorhexidine bathing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine bathing
Number of subjects: 0
Study: 30575473

Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 695

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 695
Study: 25411039

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MNs) + fish oil (FO)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MNs)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 230
Study: 22850606

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg orally after radiotracer injection
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (no pharmacological intervention)
Number of subjects: 211
Study: 19960970

Group type: EXPERIMENTAL
Intervention: Ginsenosides (GS) Capsule (50 mg) twice daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsule of equal dosage
Number of subjects: 60
Study: 17898981

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) added to Topiramate (TPM)
Number of subjects: 19
Study: 15147434

Group type: EXPERIMENTAL
Intervention: Fluvastatin (40-80 mg/day)
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2102
Study: 11585356

Group type: EXPERIMENTAL
Intervention: 15 mg of retinyl palmitate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 2 microg of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 15 mg of retinyl palmitate plus 2 microg of 1,25(OH)2D3
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9572322

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 1456

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily
Number of subjects: 1456

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 1456

Group type: COMPARATOR
Intervention: Misoprostol 200 microg four times daily
Number of subjects: 1456
Study: 7837406

Group type: EXPERIMENTAL
Intervention: DFK group (total intravenous anesthesia with droperidol, fentanyl and ketamine)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Enflurane group (enflurane‐N2O)
Number of subjects: 35

Group type: COMPARATOR
Intervention: NLA group (neuroleptic anesthesia with droperidol, pentazocine‐N2O)
Number of subjects: 35
Study: 3280587

Group type: EXPERIMENTAL
Intervention: Total body calcium by neutron activation analysis (TBC)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Single photon absorptiometry at the radius (SPA)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Dual photon absorptiometry at the spine (DPA)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography of the spine (QCT)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Cancellous bone volume from iliac crest bone biopsies
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Height loss
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Bone mass index defined using z scores from SPA, DPA, QCT, and TBC measurements
Number of subjects: 122
Study: 31944474

Group type: EXPERIMENTAL
Intervention: LOGBI
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: DPGBI
Number of subjects: 125